Recruitment of trimeric proliferating cell nuclear antigen by G1-phase cyclin-dependent kinases following DNA damage with platinum-based antitumour agents

British Journal of Cancer

Volumn 109, Issue 9, 2013, Pages 2378-2388

  He, G ^a   Kuang, J ^a   Koomen, J ^a   Kobayashi, R ^a   Khokhar, A R ^a   Siddik, Z H ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cdk inhibition; DNA damage; p21; PCNA; platinum drug; proteomic analysis

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; CYCLINE; PROTEIN P21;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS REACTION; DNA DAMAGE; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION;

EID: 84887025793     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.613     Document Type: Article

References (54)

1. Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A (2008) PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev 22(18): 2496-2506.
2. Adkins JN, Lumb KJ (2000) Stoichiometry of cyclin A-cyclin-dependent kinase 2 inhibition by p21Cip1/Waf1. Biochemistry 39(45): 13925-13930.
3. Cayrol C, Ducommun B (1998) Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene 17(19): 2437-2444.
4. Cayrol C, Knibiehler M, Ducommun B (1998) p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16(3): 311-320.
5. Chen U, Chen S, Saha P, Dutta A (1996) p21Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex. Proc Natl Acad Sci USA 93(21): 11597-11602.
6. Chopin V, Toillon RA, Jouy N, Le B,X (2004) P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 23(1): 21-29.
7. Chytil A, Waltner-Law M, West R, Friedman D, Aakre M, Barker D, Law B (2004) Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1-Cdk2 complexes. J Biol Chem 279(46): 47688-47698.
8. Coqueret O (2003) New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment?. Trends Cell Biol 13(2): 65-70.
9. Davis MT, Lee TD (1998) Rapid protein identification using a microscale electrospray LC/MS system on an ion trap mass spectrometer. J Am Soc Mass Spectrom 9(3): 194-201.
10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82(4): 675-684.
11. Estanyol JM, Jaumot M, Casanovas O, Rodriguez-Vilarrupla A, Agell N, Bachs O (1999) The protein SET regulates the inhibitory effect of p21(Cip1) on cyclin E-cyclin-dependent kinase 2 activity. J Biol Chem 274(46): 33161-33165.
12. Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ, O'Donnell M, Hurwitz J (1994) Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci USA 91(18): 8655-8659.
13. Gulbis JM, Kelman Z, Hurwitz J, O'Donnell M, Kuriyan J (1996) Structure of the C-Terminal region of p21(WAF1/CIP1) complexed with human PCNA. Cell 87(2): 297-306.
14. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75(4): 805-816.
15. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E (1995) Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6(4): 387-400.
16. He G, Kuang J, Huang Z, Koomen J, Kobayashi R, Khokhar AR, Siddik ZH (2006) Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21. Br J Cancer 95(11): 1514-1524.
17. He G, Kuang J, Khokhar AR, Siddik ZH (2011) The impact of S- and G2-checkpoint response on the fidelity of G1-Arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. Gynecol Oncol 122(2): 402-409.
18. He G, Siddik ZH, Huang Z, Wang R, Koomen J, Kobayashi R, Khokhar AR, Kuang J (2005) Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 24(18): 2929-2943.
19. Hengst L, Gopfert U, Lashuel HA, Reed SI (1998) Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1). Genes Dev 12(24): 3882-3888.
20. Hermeking H, Funk JO, Reichert M, Ellwart JW, Eick D (1995) Abrogation of p53-induced cell cycle arrest by c-Myc: Evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene 11(7): 1409-1415.
21. Iliakis G, Wang Y, Guan J, Wang H (2003) DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22(37): 5834-5847.
22. Jonsson ZO, Podust VN, Podust LM, Hubscher U (1995) Tyrosine 114 is essential for the trimeric structure and the functional activities of human proliferating cell nuclear antigen. EMBO J 14(22): 5745-5751.
23. Khokhar AR, al Baker S, Shamsuddin S, Siddik ZH (1997) Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes. J Med Chem 40(1): 112-116.
24. Kontopidis G, Wu SY, Zheleva DI, Taylor P, McInnes C, Lane DP, Fischer PM, Walkinshaw MD (2005) Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc Natl Acad Sci USA 102(6): 1871-1876.
25. Koomen JM, Li D, Xiao LC, Liu TC, Coombes KR, Abbruzzese J, Kobayashi R (2005) Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J Proteome Res 4(3): 972-981.
26. Koundrioukoff S, Jonsson ZO, Hasan S, de Jong RN, van der Vliet PC, Hottiger MO, Hubscher U (2000) A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA-interacting proteins for phosphorylation. J Biol Chem 275(30): 22882-22887.
27. Kuang J, He G, Huang Z, Khokhar AR, Siddik ZH (2001) Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints. Clin Cancer Res 7(11): 3629-3639.
28. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev 11(7): 847-862.
29. Li R, Hannon GJ, Beach D, Stillman B (1996) Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr Biol 6(2): 189-199.
30. Li Y, Dowbenko D, Lasky LA (2002) AKT/PKB phosphorylation of p21Cip/ WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 277(13): 11352-11361.
31. Lukas J, Bartkova J, Welcker M, Petersen OW, Peters G, Strauss M, Bartek J (1995) Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene 10(11): 2125-2134.
32. Maga G, Hubscher U (2003) Proliferating cell nuclear antigen (PCNA): A dancer with many partners. J Cell Sci 116(Pt 15): 3051-3060.
33. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, Ortega S, Dubus P, Barbacid M (2004) Mammalian cells cycle without the D-Type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118(4): 493-504.
34. Musgrove EA, Swarbrick A, Lee CS, Cornish AL, Sutherland RL (1998) Mechanisms of cyclin-dependent kinase inactivation by progestins. Mol Cell Biol 18(4): 1812-1825.
35. Pietenpol JA, Stewart ZA (2002) Cell cycle checkpoint signaling: Cell cycle arrest versus apoptosis. Toxicology 181-182: 475-481.
36. Poon RY, Hunter T (1998) Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells. Oncogene 16(10): 1333-1343.
37. Prabhu NS, Blagosklonny MV, Zeng YX, Wu GS, Waldman T, el Deiry WS (1996) Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interaction. Clin Cancer Res 2(7): 1221-1229.
38. Rossig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S (2001) Aktdependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol 21(16): 5644-5657.
39. Samuel T, Weber HO, Funk JO (2002) Linking DNA damage to cell cycle checkpoints. Cell Cycle 1(3): 162-168.
40. Schneider C, Newman RA, Sutherland DR, Asser U, Greaves MF (1982) A one-step purification of membrane proteins using a high efficiency immunomatrix. J Biol Chem 257(18): 10766-10769.
41. Scott MT, Morrice N, Ball KL (2000) Reversible phosphorylation at the C-Terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding. J Biol Chem 275(15): 11529-11537.
42. Sherr CJ, Roberts JM (1999) CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13(12): 1501-1512.
43. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68(5): 850-858.
44. Siddik ZH (2003) Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene 22(47): 7265-7279.
45. Siddik ZH, Mims B, Lozano G, Thai G (1998) Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line. Cancer Res 58(4): 698-703.
46. Vekris A, Meynard D, Haaz MC, Bayssas M, Bonnet J, Robert J (2004) Molecular determinants of the cytotoxicity of platinum compounds: The contribution of in silico research. Cancer Res 64(1): 356-362.
47. Vestal M, Juhasz P (1998) Resolution and mass accuracy in matrix-Assisted laser desorption ionization time-of-flight. J Am Soc Mass Spectrom 9: 892-911.
48. Waga S, Hannon GJ, Beach D, Stillman B (1994) The p21 inhibitor of cyclindependent kinases controls DNA replication by interaction with PCNA. Nature 369(6481): 574-578.
49. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993a) p21 is a universal inhibitor of cyclin kinases. Nature 366(6456): 701-704.
50. Xiong Y, Zhang H, Beach D (1992) D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71(3): 505-514.
51. Xiong Y, Zhang H, Beach D (1993b) Subunit rearrangement of the cyclindependent kinases is associated with cellular transformation. Genes Dev 7(8): 1572-1583.
52. Zhang H, Hannon GJ, Beach D (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8(15): 1750-1758.
53. Zhang H, Xiong Y, Beach D (1993) Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4(9): 897-906.
54. Zheleva DI, Zhelev NZ, Fischer PM, Duff SV, Warbrick E, Blake DG, Lane DP (2000) A quantitative study of the in vitro binding of the C-Terminal domain of p21 to PCNA: Affinity, stoichiometry, and thermodynamics. Biochemistry 39(25): 7388-7397.